Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomas
针对复发性高级别胶质瘤,采用低分割立体定向放射治疗联合纳武利尤单抗、伊匹木单抗和贝伐珠单抗的1期临床试验
期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdaf033
Sahebjam, Solmaz; Raval, Raju R; Forsyth, Peter A; Enderling, Heiko; Tran, Nam D; Arrington, John A; Macaulay, Robert; Perlow, Haley K; Palmer, Joshua D; Ghose, Jayeeta; Rajappa, Prajwal; Giglio, Pierre; Li, Zihai; Etame, Arnold B; Mokhtari, Sepideh; Cruz-Chamorro, Ruben J; Bhandari, Menal; Thapa, Ram; Robinson, Timothy J; Chen, Dung-Tsa; Yu, Hsiang-Hsuan Michael